Thujone Metabolites: Synthesis and Analysis
J. Agric. Food Chem., Vol. 49, No. 4, 2001 1921
(11) Reese, K. M. Absinthe said to be coming back in Europe.
Chem. Eng. News 1999, 77, 56.
penes including those used as food flavorings and
seasonings.
(12) Ho¨ld, K. M.; Sirisoma, N. S.; Casida, J . E. Detoxification
of R- and â-thujones (the active ingredients of ab-
sinthe): site specificity and species differences in cyto-
chrome P450 oxidation in vitro and in vivo. Chem. Res.
Toxicol. 2001, in press.
(13) Vedejs, E.; Larsen, S. Hydroxylation of enolates with
oxodiperoxymolybdenum(pyridine)(hexamethylphos-
phoric triamide), MoO5•Py•HMPA (MoOPH): 1,7,7-
Trimethyl -3-hydroxybicyclo[2.2.1]heptan-2-one (Bicyclo-
[2.2.1]heptan-2-one, 3-hydroxy-1,7,7-trimethyl-), Org.
Synth. 1986, 64, 127-134.
(14) Sheldrick, G. M. Program for the Solution and Refine-
ment of Crystal Structures; University of Go¨ttingen:
Go¨ttingen, Germany, 1997.
(15) Alaoui, M. I.; Benjilali, B.; Azerad, R. Biotransformation
of terpenic compounds by fungi. II - Metabolism of R-
(-)-thujone. Nat. Prod. Lett. 1994, 4, 263-266.
(16) Bohlmann, F.; Zeisberg, R.; Klein, E. 13C NMR-Spektren
von Monoterpenen. Org. Magn. Reson. 1975, 7, 426-
432.
ABBREVIATIONS USED
mCPBA, m-choroperbenzoic acid; MoOPH, oxodiper-
oxymolybdenum(pyridine)(hexamethylphosphoric tria-
mide); MOX, methyloxime reagent or derivative; MST-
FA,
N-methyl-N-(trimethylsilyl)trifluoroacetamide;
NOESY, nuclear Overhauser effect spectroscopy; TMS,
trimethylsilyl substituent or derivative.
ACKNOWLEDGMENT
We thank our laboratory colleagues Shinzo Kagabu,
David Lee, Gary Quistad, Yoffi Segall, and Nanjing
Zhang for helpful suggestions. Crystallography was
done by Marilyn Olmstead and Håkon Hope (Depart-
ment of Chemistry, University of California, Davis), and
1H NMR NOESY experiments were conducted by Corey
Liu and Ted Barnum (Department of Chemistry, Uni-
versity of California, Berkeley).
(17) Kutney, J . P.; Chen, Y.-H. The chemistry of thujone.
XVII. The synthesis of ambergris fragrances and related
analogues. Can. J . Chem. 1994, 72, 1570-1581.
(18) House, H. O.; Thompson, H. W. Synthesis of ∆8,9- and
Su p p or tin g In for m a tion Ava ila ble: Figure S1 giving
two-dimensional NOESY of 3â. Figure S2 giving mass spectra
of 4R and its TMS and MOX derivatives using positive
chemical ionization and postulated fragmentation pathways.
Table S1 giving GC tr values and proposed MS fragmentation
patterns for thujol and neothujol and their TMS derivatives.
This material is available free of charge via the Internet at
http://pubs.acs.org.
∆
9,10-octal-1-one. J . Org. Chem. 1961, 26, 3729-3734.
(19) Williamson, K. L.; Coburn, J . I.; Herr, M. F. The acid-
catalyzed rearrangement of enol ester epoxides. J . Org.
Chem. 1967, 32, 3934-3937.
(20) Smith, S. C.; Heathcock, C. H. A convenient procedure
for the synthesis of bis-steroidal pyrazines: Models for
the cephalostatins. J . Org. Chem. 1992, 57, 6379-6380.
(21) Zhu, Y.; Manske, K. J .; Shi, Y. Dual mechanisms of acid-
catalyzed rearrangement of enol ester epoxides: Enan-
tioselective formation of R-acyloxy ketones. J . Am.
Chem. Soc. 1999, 121, 4080-4081.
(22) McCormick, J . P.; Tomasik, W.; J ohnson, M. W. R-Hy-
droxylation of ketones: Osmium tetroxide/N-methyl-
morpholine-N-oxide oxidation of silyl enol ethers. Tet-
rahedron Lett. 1981, 22, 607-610.
LITERATURE CITED
(1) Tori, K. Conformations of R- and â-thujones. Chem.
Pharm. Bull. 1964, 12, 1439-1446.
(2) Gruenwald, J .; Brendler, T.; J aenicke, C., Eds. PDR for
Herbal Medicines; Medical Economics: Montvale, NJ ,
1998; pp 1181-1183.
(3) Ho¨ld, K. M.; Sirisoma, N. S.; Ikeda, T.; Narahashi, T.;
Casida, J . E. R-Thujone (the active component of ab-
sinthe): γ-aminobutyric acid type A receptor modulation
and metabolic detoxification. Proc. Natl. Acad. Sci.
U.S.A. 2000, 97, 3826-3831.
(23) Umbreit, M. A.; Sharpless, K. B. Allylic oxidation of
olefins by catalytic and stoichiometric selenium dixoide
with tert-butyl hydroperoxide. J . Am. Chem. Soc. 1977,
99, 5526-5528.
(24) Klinck, R. E.; de Mayo, P.; Stothers, J . B. Selenium
dioxide oxidation product of sabinol. Chem. Ind. 1961,
471-472.
(4) Anonymous. Medicinal herbs: NTP extracts the facts.
Environ. Health Perspect. 1999, 107, A604-A605.
(5) Blumenthal, M., Ed. The Complete German Commission
E Monographs: Therapeutic Guide to Herbal Medicines;
American Botanical Council: Austin, TX, 1998; pp 664-
665.
(6) Arnold, W. N. Absinthe. Sci. Am. 1989, 6, 112-117.
(7) Arnold, W. N. Vincent van Gogh: Chemicals, Crises, and
Creativity; Birkhau¨ser: Boston, 1992; pp 101-137.
(8) Conrad, B., III. Absinthe: History in a Bottle; Chronicle
Books: San Francisco, CA, 1988.
Received for review December 4, 2000. Revised manuscript
received February 20, 2001. Accepted February 21, 2001. This
work was supported by grant R01 ES08419 from the National
Institute of Environmental Health Sciences (NIEHS), NIH,
and its contents are solely the responsibility of the authors
and do not necessarily represent the official views of the
NIEHS, NIH.
(9) Strang, J .; Arnold, W. N.; Peters, T. Absinthe: what’s
your poison? Br. Med. J . 1999, 319, 1590-1592.
(10) Vogt, D. D.; Montagne, M. Absinthe: behind the emerald
mask. Int. J . Addict. 1982, 17, 1015-1029.
J F001445+